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ABSTRACT
Objectives: We aimed to demonstrate cell-cell adhesion and apoptotic changes in preeclamptic placentas by examining 
the expression of CD44 and IL-10. 
Material and methods: Placenta samples of 15 preeclamptic and 15 healthy 35–38th week-pregnant women were involved 
in the study. Tissue samples were taken only from the maternal side of the placenta and fixed in 10% formaldehyde, then 
blocked in paraffin wax and 5 μm-thick sections were cut and stained with Masson Trichrome. Antigen retrieval was per-
formed for sections, incubated with CD44 antibody and anti-IL-10 antibody. After the application of streptavidin peroxidase 
followed by AEC chromogen solution, sections were counterstained with Mayer hematoxylin. 
Results: In the preeclampsia group, increased CD44 positive expression was observed in maternal decidua cells and fibro-
blast cells close to root villi. CD44 was positively expressed in muscle cells around the blood vessels, mucosal connective 
tissue areas, syncytial nodes, and syncytial bridges. In the preeclampsia group, significant increased IL-10 expression was 
seen in subendothelial layers of the medium-sized vessels in the maternal region. IL-10 was also positively expressed in 
decidua cells outside the vessels, and inflamed connective tissue areas, chorionic villus cells with intense inflammation in 
intervillous spaces. 
Conclusions: CD44 was found to be an essential molecule in the regulation of vascular permeability, inflammatory 
response, activation of the cells, cell-to-cell interaction, and the signaling pathways to which they are associated. Since 
IL-10 regulates appropriate pregnancy outcomes and contributes to the balance of anti-inflammatory signals via both 
paracrine and autocrine regulators of trophoblast activity, we proposed that it might be a key to elucidate the etiology of 
preeclampsia with CD44 receptor.
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INTRODUCTION
Preeclampsia, a complication of pregnancy, occurs in 
5–8% of pregnancies. Preeclampsia, which is among the 
hypertensive diseases of pregnancy, is one of the causes of 
maternal deaths all around the world [1]. Preeclampsia is 
diagnosed by onset of new hypertension and proteinuria 
after 20th week of gestation. İn the absence of proteinuria, 
preeclampsia can be diagnosed with  hypertension accom-
panying by evidence of systemic disease (such as elevated 
of liver enzyme or thrombocytopenia) [2]. Preeclampsia 
is a risk factor for complications such as maternal renal 
failure, liver involvement, organ dysfunction, uteroplacen-
tal insufficiency, fetal growth retardation. Insufficiency of 
trophoblastic invasion of the placenta is important in the 
pathophysiology of preeclampsia. Changes in the spiral ar-
teries are impaired in preeclampsia, cause placenta hypoxia, 
and decreased fetal blood circulation [3].
The cause of maternal clinical symptoms in preeclamp-
sia is systemic endothelial dysfunction. Endothelium-de-
pendent vascular tone control and vasoconstriction lead to 
hypertension; increased capillary permeability leads to loss 
of fluid into the third cavity, hemoconcentration and edema; 
increased glomerular permeability leads to proteinuria and 
coagulation mechanism leads to extensive intravascular 
coagulation. In preeclamptic patients, inadequate migration 
and invasion of cytotrophoblasts prevent formation of nor-
mal physiological changes in the spiral arteries, or they are 
confined to only decidua part of the spiral arteries [2, 4, 5].
Endothelial cells, trophoblasts and the immune cells in 
the endometrium during the implantation can synthesize 
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many cytokines. A disorder in the cytokine environment 
may cause problems in the formation of placenta or may 
cause wide endothelial dysfunction, eventually leading to 
the development of preeclampsia [6].
Hyaluronic acid (HA) is a repeating non-sulfated glycosami-
noglycan polymer of recurrent disaccharide units of N-acetyl 
glucosamine and p-gluconic acid. HA is an important compo-
nent of extracellular matrix (ECM) of especially fast growing 
and remodeling tissues and plays a role in a variety of cellular 
functions including differentiation and inflammation [7].
CD44 mediates cell-to-cell and cell-to-matrix interac-
tions through the hyaluronic acid (HA) receptor. It also plays 
an important role in cell adhesion and migration, tumor 
growth and progression via HA [8]. Apart from HA, CD44 has 
affinity and other ligands, such as osteopontin, collagen and 
matrix metalloproteinases (MMPs).
IL-10 is the main regulator of the inflammatory process 
and is present as a major immunomodulatory agent in the 
feto-maternal interface. The trophoblasts [9], decidua mac-
rophages [10], natural killer (NK) cells [11] produce IL-10. 
It is most expressed at the feto-maternal interface of the ex-
tra villous cytotrophoblasts during the early pregnancy and 
villous cytotrophoblasts in late pregnancy [7]. Human leuko-
cyte antigen (HLA-G) expression is inhibited lysis of maternal 
NK cells and induced by IL-10, which contributes to fetal 
allograft tolerance [12]. IL-10 also increases the resistance 
of trophoblasts to Fas-mediated apoptosis [13]. In our study, 
we aimed to demonstrate cell-cell adhesion and apoptotic 
changes in preeclamptic placentas.
MATERIAL AND METHODS
The study was approved by the Medical Committee of 
Diyarbakir Maternity and Child Health Hospital. All protocols 
were approved by local ethics committee. All patients were 
informed and signed consent form. All placenta tissues were 
provided from the Diyarbakır Maternity and Child Health 
Hospital (Department of Obstetrics and Gynecology). The 
study included 15 pregnant patients with placenta previa 
and 15 healthy pregnant patients between gestational age.  
Preeclampsia criteria were defined by hypertension (systolic 
blood pressure ≥ 140 mmHg and/or diastolic blood pres-
sure ≥ 90 mmHg) and proteinuria (> 300 mg in 24 h). Clinical 
blood tests were gathered and experimental biochemical 
analysis were performed on blood samples of patients. The 
placental tissues were immersed in 10% buffered formalde-
hyde. They were dehydrated in ascending alcohol series, 
cleaned in xylene and embedded in paraffin. Then 4 µm 
sections were cut and stained with Trichrom Masson.
Immunohistochemical examination
All sections were bought to distilled water and for fur-
ther immunohistochemical examination. Antigen retrieval 
process was performed in citrate buffer solution (pH: 6.0) 
for 10 minutes in a microwave oven at 700 W. Sections were 
permitted to cool down at room temperature for 30 minutes 
and washed in distilled water 2 × 5 minutes. 3% hydrogen 
peroxide (H2O2) was used for endogen peroxidase block-
ing for 10 minutes. Samples were rinsed in distilled water 
and washed in PBS. The sections were then incubated with 
mouse monoclonal anti-CD44 antibody (catalog no: sc-7297, 
Santa Cruz Biotechnology, Inc., Texas 75220 USA, 1: 100) 
and Mouse monoclonal anti-IL-10 antibody (catalog no: 
ab34843, Abcam, Cambridge, MA 02139-1517, USA,1:100) 
overnight at + 4oC. The next day,  sections were cleaned with 
PBS and secondary antibody solution (Biotinylated Goat 
Anti-Mouse, Lab Vision) was applied for 14 minutes. Fol-
lowing PBS, streptavidin peroxidase solution (Streptavidin 
Peroxidase, Lab Vision) was performed for 15 minutes. Slides 
were washed 3 times in PBS and DAB chromogen solution 
were applied for 8 min. Sections were washed with distilled 
water and counter stained with 2 min Mayer hematoxylin. 
Slides were imaged with imager A2 Zeiss light microscope.
Semiquantitative scaling of sinsistial knot, congestion 
in blood vessels,fibrinoid acumulation  nflamation and de-
generation in decidua were carried out. The intensity of 
these changes were graded from 0 to 4 (0: no change, 1: low, 
2: moderate, 3: intense 4;most intense). Semiquantitative 
scaling of immunoreactivity was carried out. The intensity 
of staining was graded from 0 to 4 (0: no staining, 1: faint 
staining, 2: moderate staining, 3: intense staining, 4;most 
intense staining).
Statistical Analysis
Statistical calculations R version 3.2.3 (2015–12–10), 
Copyright (C) 2015 The R Foundation for Statistical Com-
puting free software was used in the computer package 
program. Student t and Mann-Whitney U tests were used for 
statistical analysis. Statistical evaluations for p < 0.05 were 
considered significant.
RESULTS
Independent Samples Test evaluation results, frequency 
values of categorical variables, Fisher’s Exact Test calcula-
tions and statistical significance values were given in the 
tables below and statistical histopathological evaluation 
was evaluated according to these data. Histopathologic 
scoring and immunohistochemical expression p values are 
shown in the Table 1.
The characteristics of normotensive and preeclampsia 
patients are shown in Table 1. The placentas of the control 
and preeclampsia groups were compared histologically. 
CD44 and IL-10 expressions were also analyzed. Clinical 
results of normal pregnancy and preeclampsia pregnancy 
were compared (Fig. 1–4). 
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Histopathological Analysis
In placentas of control group, there were slightly en-
larged medium-sized blood vessels large chorionic villi, 
regular syncytial cells with small fibrinoid structures and 
knots. The collagen fibers were organized in parallel and 
thin bands. Small villi structures in the intervillous area 
were normal (Fig. 4A). The chorionic villi of the preeclamp-
tic placenta showed syncytial node, syncytial edema, and 
increased collagen fiber increase. In addition, heterochroma-
tin appearance in syncytial bridges, degenerative changes 
in large nuclei, dilated and congested blood vessels and 
inflammation outside the vessels were observed (Fig. 4B). 
High CD44 expression was observed in vascular basal 
membrane of cytotrophoblast and fibroblast cells in preec-
lampsia group. CD44 activity in the control group sections 
showed mild positive CD44 expression in the maternal decidua 
cells and fibroblast cells close to the root villi. Negative CD44 ex-
pression was observed in muscle cells around the blood vessels, 
mucous connective tissue areas, and syncytial cells (Fig. 5A).
Preeclampsia group: Increased CD44 positive expression 
was observed in maternal decidua cells and fibroblast cells 
close to root villi. CD44 was positively expressed in muscle cells 
around the blood vessels, mucosal connective tissue areas, 
syncytial nodes and syncytial bridges (Fig. 5B). Control group: 
IL-10 expression in trophoblast cells and connective tissue 
cells in floating villi was negative while it was positive in mac-
rophage cells, syncytial nodes and bridges of root villi (Fig. 5C).
Preeclampsia group: Significant increased IL-10 expres-
sion was seen in sub endothelial layers of the medium-sized 
vessels in the maternal region. IL-10 was also positively 
expressed in decidua cells outside the vessels and inflamed 
connective tissue areas, chorionic villus cells with intense 
inflammation in intervillous spaces (Fig. 5D).
Table 1. Independent Sample T-test result of parameters
Group Statistics
Groups N Mean Std. Error Mean p value
Age
Control 15 28.20 1.72
> 0.05
Preeclampsia 15 31.40 2.74
Gravida
Control 15 2.53 0.59
> 0.05
Preeclampsia 15 3.60 0.76
Parite
Control 15 1.07 0.42
> 0.05
Preeclampsia 15 2.13 0.58
TAsist
Control 15 113.00 2.65
= 0.00
Preeclampsia 15 154.20 4.32
TAdiast
Control 15 71.53 1.75
= 0.00
Preeclampsia 15 96.33 1.45
Hemoglobin
Control 15 12.19 0.40
< 0.05
Preeclampsia 15 10.95 0.44
Platelet
Control 15 258.33 18.32
> 0.05
Preeclampsia 15 278.60 25.60
Glucose
Control 15 78.87 2.73
> 0.05
Preeclampsia 15 75.54 3.31
Urea
Control 15 16.06 1.04
> 0.05
Preeclampsia 15 18.28 1.60
Kreatinin
Control 15 0.59 0.01
> 0.05
Preeclampsia 15 0.58 0.02
ALT
Control 15 11.07 1.33
> 0.05
Preeclampsia 15 19.40 5.27
AST
Control 15 22.07 2.98
> 0.05
Preeclampsia 15 27.07 6.90
Urine Protein
Control 15 143.27 7.82
= 0.00
Preeclampsia 15 848.13 129.30
Statistically p < 0.05 means, significantly difference between groups
Age Gravida Parite Hemoglobin Urea Kreatinin ALT AST
Control
Preelampsia
40
30
20
10
0
*
Figure 1. Independent samples T-test results of variables; Age, Gravia, Parite, Hemoglobin, Urea, Kreatinin, ALT and AST/ Different upper symbols of 
each column shows significantly difference between groups. (*p < 0.05)
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DISCUSSION
Preeclampsia (PE) is a pregnancy complication, which 
is the leading cause of maternal and fetal morbidity and 
mortality and occurs after 20 weeks of gestation. PE is 
a multisystem disease accompanied by hypertension and 
proteinuria (≥ 300 mg/24 h) or other symptoms (cerebral 
and vision symptoms, pulmonary edema, elevated serum 
creatinine levels, decreased platelet count [14, 15]. If systolic 
blood pressure is 160 mmHg or more and the diastolic 
blood pressure is 110 mmHg or more, it is defined as severe 
preeclampsia [15].
Hypoxia plays an important role in preeclampsia which 
is a pregnancy-specific syndrome characterized by maternal 
hypertension and proteinuria. Normally, the transformation 
of maternal spiral arteries occurs during placental develop-
ment in the first weeks of pregnancy and this transforma-
tion is impaired in preeclampsia resulting in reduction of 
placental perfusion that triggers the inflammatory response. 
Starting by the second trimester of pregnancy, this inflam-
matory response elicits classic symptoms and findings in 
the diagnosis of preeclampsia. Systemic vasoconstriction 
and hypertension develop due to damage to the endothe-
lial area of the vessels in the maternal circulation [16–19]. 
Hemolysis occurs because of systemic capillary endothelial 
damage, elevated liver enzymes and thrombocytopenia 
are together defined as HELLP Syndrome [17, 19]. Because 
of invasion of spiral trophoblast migration in PE, recurrent 
spiral arteries of the uterus may be impaired [20, 21].
Decidua arteriopathy results in a decrease in blood flow 
to the placental villi and distal villous hypoplasia. In the 
preeclampsia group of our study, chorionic villus syncytial 
node, syncytial edema, increased collagen fiber, hetero-
chromatin appearance in syncytial bridges and degenera-
tive changes in large nuclei were observed. In addition, 
dilatation and congestion in the blood vessels, inflamma-
tion around the vessels, showed the pathological condition 
resulting from hypoxia.
CD44 angiogenesis, resulting in endothelial cell prolifera-
tion, migration and differentiation, may contribute to syner-
gistic stimulation. Immunohistochemical analysis has shown 
that endothelial cells, basement membrane and fibroblast cells 
express high CD44 levels. The role of CD44/hyaluronic acid 
interaction reported to be important for the differentiation of 
endothelial cells during angiogenesis [22]. Rui Zhu et al. [23] 
showed expression and function of hyaluronic acid/CD44 of 
Figure 2. Independent samples T-test results of variables; Platelet, TAsist, TAdiast and glucose. Different upper symbols of each column shows 
significantly difference between groups. (*p = 0.00)
Control
Preelampsia
400
300
200
100
0
Platelet TAsist TAdiast Glucose
*
*
Figure 3. Independent samples T-test result of Urine. Different upper 
symbols of each column shows significantly difference between 
groups
1000
800
600
400
200
0
Urine Protein
Control Preelampsia 
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Figure 4. Graphical view of histopathological and immunohistochemical analyzes
Control
Preelampsia
4
3.5
3
2.5
2
1.5
1
0.5
0
Sinsistial knot Congestion in
blood vessels
Fibrinoid
acumulation
Inamation CD44Degeneration
in decidua
IL-10
Expression
1.4
3.4 3.4 3.4
3.8
0.67
0.930.87
0.53
1.2
3.2 3.27
3.67
0.8
Figure 4A. Normotansive group: 
Trichrom-Masson stainingX40 
Immunohistochemical analysis
Figure 4B. Preeclampsia group 
Trichrom-Masson stainingX40
Figure 5A. Normotansive group: 
CD44 immunstaining Bar 50µm
Figure 5B. Preeclampsia group 
CD44 immunstaining Bar 50µm
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human decidua stromal cells in the first trimester of pregnancy. 
They reported Hyaluronic acid (HA) stimulate proliferation 
and growth of decidua stromal cells by autocrine signaling, 
high levels of HA provide maintenance of normal pregnancy 
while low content and degradation of HA may cause early 
pregnancy loss.The presence of a functional CD44 molecule 
in the human placenta plays a role in the stabilization and 
orientation of the HA network, which is important in maintain-
ing the placental structural integrity for CD44 [24]. CD44 is 
the main cell surface receptor for hyaluronic acid (HA), an in-
tegral component of the extracellular matrix and expressed 
in different cell types including epithelial, mesenchymal and 
hematopoietic cells, as well as immune cells. CD44 expression 
increases during inflammation and its variants of CD44v3 and 
CD44 v6 are also upregulated. CD44 was reported to partici-
pate in T cell activation, migration, and cell adhesion to HA 
during the immune response [25].
A study showed that in the presence or absence of 
placental pathology, hyaluronic acid was a key glycan in 
the regulation and distribution of other hyaluronic acids 
the organization and stabilization of extracellular matrix 
and glycocalyx, in the distribution of tissues, as well as 
HA fragments with different molecular weights interact with 
different types of CD44 receptors. HA negatively regulates 
the vascular permeability by activating signaling pathways 
associated with the formation of the cortical layer of ac-
tin microfilaments and intracellular contacts. It positively 
induces vascular permeability by triggering activation of 
the protease-activated receptor (PAR), thereby promoting 
the formation of actin stress fibrils and disruption of con-
tact between cells [26, 27]. In our study, CD44 expression 
was observed in the maternal decidua cells, fibroblast cells 
close to the root villi, muscle cells around the blood vessels 
and mucosal connective tissue. In addition, the positive 
expression in the syncytial knots and bridges was thought 
to be important in altering the placental tissue structure 
of the secreting cells. Because HA regulates the systemic 
inflammatory response, different molecular weight hyalu-
ronic acids have been reported to have various effects on 
pregnancy and may even promote pathology. According 
to the pathogenesis of PE, the main clinical manifestations 
of the disease are associated with insufficient localization, 
excessive systemic inflammatory response and endothelial 
dysfunction [28]. The role of cytokines in the pathogenesis 
of PE is important. Cytokines have many regulatory effects 
on interaction, uptake, activation, stimulation, killing and 
suppression of immune and non-immune cells. Cytokines 
Figure 5D. Preeclampsia group 
IL-10 immunstaining Bar 50µm
Figure 5C. Normotansive group: 
IL-10 immunstaining Bar 50µm
Table 2. Histopathological scoring and immunohistochemistry 
expression results
Groups n Mean Std. Error p value
Sinsistial knot
Control 15 1.40 0.13
= 0.000
Preeclampsia 15 3.40 0.13
Congestion in 
blood vessels
Control 15 0.67 0.48
= 0.000
Preeclampsia 15 3.80 0.41
Fibrinoid 
acumulation
Control 15 0.87 0.51
= 0.000
Preeclampsia 15 3.40 0.63
Inflamation
Control 15 0.93 0.59
= 0.000
Preeclampsia 15 3.40 0.63
Degeneration in 
decidua
Control 15 0.53 0.51
= 0.000
Preeclampsia 15 3.20 0.56
CD44
Control 15 1.20 0.77
= 0.000
Preeclampsia 15 3.27 0.45
IL-10 Expression
Control 15 0.80 0.56
= 0.000
Preeclampsia 15 3.67 0.61
Mann-Whitney U test result of parameters; statistically p < 0.05 means, 
significantly difference between groups
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were reported to be involved in various events such as 
ovulation, implantation, placement and delivery during 
pregnancy. Cytokines such as TNFα stimulate the binding 
of CD44 expressed on peripheral monocytes to HA and 
CD44 expression, and adhesion to HA in hematopoietic 
cells is altered as a function of the cell activation stage [29].
Cytokines such as granulocyte-macrophage colony 
stimulating factor (GM-CSF), colony-stimulating factor-1, 
IL-3 and IL-10 contribute to the success of pregnancy [30]. 
In the first and second trimester placental tissues, IL-10 levels 
were moderate and higher in the third trimester period. 
Decidua cells, trophoblast cells and maternal uterine lym-
phocyte subgroups expresses IL-10 [31]. Abnormalities in IL-
10 production may alter trophoblast invasion to uterus. It is 
proposed that Human Leukocyte Antigen-G (HLA-G), an an-
tigen expressed by trophoblast, may regulate decidua cells 
expression and thus protecting maternal-fetal tolerance 
network. It is also emphasized that the role of inflammation 
is important for successful pregnancies. Chronic inflamma-
tion and lack of dissolution of anti-inflammatory cytokine 
producing cells can lead to various pregnancy disorders 
due to multiple factors. IL-4 and IL-10 play an important role 
in the successful pregnancy, and a deficiency of them was 
reported to contribute to infertility, spontaneous abortion 
and hypertensive pregnancy disorders [32]. The evaluation 
of placental tissue and serum samples from preeclamptic 
women showed that IL-10 production decreased. Endovas-
cular interactions between trophoblasts and endothelial 
cells was reported to be impaired [33, 34]. In our study, 
there was a significant increased IL-10 expression in sub en-
dothelial layers of medium-type blood vessel in the maternal 
region. Positive IL-10 expression was also found in inflamed 
connective tissue areas and decidua cells near the vessels. In 
addition, IL-10 activity increased in chorionic villus cells and 
intervillous spaces with intense inflammation.
CONCLUSIONS
In conclusion, CD44 has been found to be an impor-
tant molecule in regulation of vascular permeability, in-
flammatory response, and in activation of the cells and 
the cell-to-cell interaction and the signaling pathways to 
which they are associated. In a study, tumor necrosis factor 
(TNF)-α and interleukin (IL)-10 was studied as modulator on 
CD44 expression in Langerhans cells. They reported that 1) 
TNF-α significantly upregulates CD44 expression in a con-
centration-dependent manner and 2) IL-10 downregulates 
CD44 expression in a concentration-dependent manner. 
IL-10, a key regulator of immune system, not only has im-
munomodulatory activity, but also provides direct benefit 
to vasculature and promotes successful cellular interactions 
at the fetal-maternal interface. We thought that IL-10 act like 
TNF-α by upregulating CD44 expression. Thus, we speculate 
that IL-10 is important factor in blood cells and their activa-
tion by inducing HA to bind CD44.
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